Chuanhai Cao received his Ph.D. degree in medical microbiology and virology from the Tianjin Medical University, Tianjin, China, and currently, he is an Assistant Professor at the Department of Pharmaceutical Sciences in the College of Pharmacy, University of South Florida, Tampa, Fla, USA. He has published over 50 peer‐reviewed publications. His research interests are focused on infectious diseases, HIV and HCV, neurodegenerative diseases, Alzheimer’s disease (AD), and Parkinson’s disease (PD). Recently, his research team has been focusing on how our immune system is affected by aging and how this immune declining is associated with the onset and progress of Alzheimer’s disease and Parkinson’s disease. They also strove to delay or slow down the progress of AD by modulating the immune system using natural and nutraceutical products, such as coffee, caffeine, melatonin, and other herb extractions. Cao has led his team to develop several immunotherapies against AD and PD. They are the first research team to use antigen‐sensitized dendritic cells as vaccine against AD and PD. Their idea on how to delay onset of AD has been adopted and proved to be very effective by AD patients. Their research publications have been reported by many worldwide news media. In addition, Cao holds two patents and has six patents pending now.
Biography Updated on 4 November 2013